{
  "docId": "019de074-01e2-758c-9358-12040e004419",
  "docSlug": "a93b7129565926c7be538a038211eae0",
  "documentTitle": "Larimar Therapeutics | Results Presentation Deck | 15 slides",
  "authorId": "larimar-therapeutics",
  "authorName": "Larimar Therapeutics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 15,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "appendix_methodology",
  "function": "present_framework",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a timeline-style visualization to represent dosing schedules for different cohorts.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-01e2-758c-9358-12040e004419/6",
  "deckHref": "/decks/019de074-01e2-758c-9358-12040e004419",
  "deckJsonHref": "/decks/019de074-01e2-758c-9358-12040e004419.json",
  "deckAnchorHref": "/decks/019de074-01e2-758c-9358-12040e004419#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.4,
        "w": 0.9,
        "x": 0.03,
        "y": 0.0045
      },
      "kind": "diagram",
      "text": "Cohort dosing schedules with PK sampling points",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f1c94a2f-6cc6-46b5-b517-0718af4830a8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.3,
        "x": 0.03,
        "y": 0.0092
      },
      "kind": "disclaimer",
      "text": "Each cohort included patients randomized to receive placebo. Studies included a follow-up period of 30 days. BL, baseline; PK, pharmacokinetic.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4ea97364-bc58-4320-aab0-d5df314b9203",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.25,
        "x": 0.65,
        "y": 0.0088
      },
      "kind": "legend",
      "text": "PK sampling; No CTI-1601 dose",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a7081c70-d9df-4bc3-bde5-84dd0ec3bdc0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.4,
        "x": 0.03,
        "y": 0.0026
      },
      "kind": "list",
      "text": "NCT04176991; Phase 1, double-blind, placebo-controlled; A single dose of CTI-1601 or placebo was administered subcutaneously",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4139a686-7b47-44de-b1e5-e32beb1cccd3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.4,
        "x": 0.51,
        "y": 0.0026
      },
      "kind": "list",
      "text": "NCT04519567; Phase 1, double-blind, placebo-controlled; CTI-1601 or placebo was administered subcutaneously",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7ca277e7-3e77-41fb-90f7-29d6489eb6c5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.25,
        "x": 0.51,
        "y": 0.0018
      },
      "kind": "paragraph",
      "text": "Multiple Ascending Dose",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bddb721a-fcd7-450a-bbe6-f8e9bc822275",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.25,
        "x": 0.03,
        "y": 0.0018
      },
      "kind": "paragraph",
      "text": "Single Ascending Dose",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "de708b8a-1df0-4b9f-b7c0-90a8f5cd6ed0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.09,
        "w": 0.25,
        "x": 0.02,
        "y": 0.03
      },
      "kind": "title",
      "text": "Study Design",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b7b53dfa-f322-4961-afb0-7cf1b31b6277",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "e8a458ad-85ff-4f2a-a2f5-92b4d5efeffd",
      "evidence": "Visual representation of dosing intervals and sampling points over time.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 14,
      "from": 6,
      "name": "Hypothesis Test",
      "slug": "42-hypothesis-test",
      "bestFor": "Strategy validation, due diligence, research presentations",
      "matchId": "39c35451-875a-4343-a0e1-2d4d245251be",
      "evidence": "Study design and results",
      "position": 1,
      "objective": "Does CTI-1601 work as intended?",
      "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)",
      "confidence": 0.7,
      "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}